Clinical Trial Update: Heart Rate Variability Biofeedback for Smoking Cessation Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating heart rate variability biofeedback as a treatment for smoking cessation has completed enrollment and posted results on 2024-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Tobacco Smoking | Phase 2 | Status: COMPLETED | Results posted: 2024-05-01